Dr. Shulman is the George R. Cowgill Professor of Medicine and Cellular & Molecular Physiology at Yale.He is also Co-Director of the Yale Diabetes Research Center and an Investigator Emeritus of the Howard Hughes Medical Institute. Dr. Shulman has pioneered the use of magnetic resonancespectroscopy combined with mass spectrometry to non-invasively examine intracellular glucose and fatmetabolism in humans and transgenic rodent models that have led to several paradigm shifts in ourunderstanding of type 2 diabetes (T2D), including the molecular mechanisms by which lipids promotes liver and muscle insulin resistance, as well as developing new drugs for the treatment of T2D, nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Dr. Shulman is the recipient of the Stanley J. Korsymeyer Award from the American Society for Clinical Investigation, the Outstanding Clinical Investigator Award from the Endocrine Society, the Solomon Berson Award from the American Physiological Society and the Banting Medal for Lifetime Scientific Achievement from the American Diabetes Association. Dr. Shulman is a Fellow ofthe American Association for the Advancement of Science, Inaugural Fellow of the American Physiological Society, Mastership in the American College of Physicians, Mastership in the American College of Endocrinologists and he has been elected to the American Society for Clinical Investigation, the Associationof American Physicians, the National Academy of Medicine, the American Academy of Arts and Sciences and the National Academy of Sciences.